Hidden heart risk: routine cancer scans could reveal cardiovascular danger in breast cancer survivors

NCT ID NCT07703033

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether measuring calcium buildup in heart arteries from routine radiotherapy planning CT scans can identify breast cancer patients at risk for heart disease. Researchers will share this personalized risk information with patients and their doctors to see if it influences treatment decisions and patient satisfaction. The goal is to improve long-term heart health in breast cancer survivors without extra scans or radiation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
measuring coronary artery calcifications (Agatston score) using routine radiotherapy planning CT scans and communicating the associated risk of cardiovascular disease to the patient
What this could lead to
If successful, this approach could help identify breast cancer patients at high risk for heart disease earlier, leading to better preventive care and improved long-term health.
What could go wrong
This is a decision-impact study, not a treatment trial. It measures whether sharing risk information changes care, but it may not directly improve health outcomes. Some patients may experience anxiety from learning their heart risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amsterdam University Medical Center

    NOT_YET_RECRUITING

    Amsterdam, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Champalimaud Foundation

    NOT_YET_RECRUITING

    Lisbon, Portugal

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • LMU University Hospital

    NOT_YET_RECRUITING

    München, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • RegionH

    NOT_YET_RECRUITING

    Copenhagen, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • St. Antonius Hospital

    RECRUITING

    Utrecht, Netherlands

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.